Effects of dexamethasone on apoptosis-related cell death after spinal cord injury

Journal of Neurosurgery

Volumn 96, Issue 1 SUPPL., 2002, Pages 83-89

  Zurita, Mercedes ^a   Vaquero, Jesús ^a   Oya, Santiago ^a   Morales, Carmen ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Apoptosis; Apostain; Dexamethasone; Rat; Spinal cord injury

Indexed keywords

APOSTAIN; DEXAMETHASONE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLIA CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PARAPLEGIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY;

EID: 0036121224     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/spi.2002.96.1.0083     Document Type: Article

References (70)

1. Remarks on the histopathological changes in the spinal cord due to impact. An experimental study
2. Experimental models for spinal cord injury research. Physical and physiological considerations
3. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury
4. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat
5. Spinal cord injury models: Neurophysiology
6. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1 Year follow-up data: Results of the second National Acute Spinal Cord Injury study
7. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord
8. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
9. Morphological evidence suggesting apoptotic nuclei in spinal cord injury
10. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death
11. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
12. Mechanisms and functions of cell death
13. Apoptosis after traumatic human spinal cord injury
14. The use of apostain in identifying early apoptosis
15. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis
16. Glucocorticoid regulation of motoneuronal parameters in rats with spinal cord injury
17. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
18. The neuroprotective pharmacology of methylprednisolone
19. Involvement of an ICAM- 1dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats
20. Roles of nitric oxide in compression injury of rat spinal cord
21. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care
22. Pathogenesis of spinal cord injury and newer treatments. A review
23. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
24. Neuronal cell death in the ischemic spinal cord: The effect of methylprednisolone
25. Effect of mexiletine on lipid peroxidation and early ultrastrutural findings in experimental spinal cord injury
26. Induction and its spread of apoptosis in rat spinal cord after mechanical trauma
27. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL 1 acting as an antiapoptotic factor
28. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics
29. Delayed neuronal death in the gerbil hippocampus following ischemia
30. Application of dexamethasone in the treatment of acute spinal cord injury
31. Local spinal cord blood flow in experimental traumatic myelopathy
32. Edema development and ion changes in rat spinal cord after impact trauma: Injury dose-response studies
33. Apoptosis and expression of Bcl- 2 after compression trauma to rat spinal cord
34. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat
35. Neuronal and glial apoptosis after traumatic spinal cord injury
36. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury
37. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma
38. Nitric oxide synthase in cerebral ischemia. Possible contribution of nitric oxide synthetase activation in brain microvessels to cerebral ischemic injury
39. Activation and cleavage of caspase- 3 in apoptosis induced by experimental cerebral ischemia
40. Apoptosis occurs after cerebral contusion in humans
41. Steroid hormones protect spinal cord neurons from glutamate toxicity
42. Current concepts in the management of acute spinal cord injury
43. Dexamethasone-induced apoptosis in peripheral T lymphocytes from patients with asthma
44. Altered norepinephrine metabolism following experimental spinal cord injury. 1: Relationship to hemorrhagic necrosis and post-wounding neurological deficits
45. Altered norepinephrine metabolism following experimental spinal cord injury. 2: Protection against traumatic spinal cord hemorrhagic necrosis by norepinephrine synthesis blockade with alpha-methyltyrosine
46. Alteration in extracellular amino acids after traumatic spinal cord injury
47. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain
48. Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury
49. Synthesis and biological effects of NO in malignant glioma cells: Modulation by cytokines including CD95L and TGF-beta, dexamethasone and p53 gene transfer
50. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat
51. Glucocorticoids induce apoptosis in human monocytes: Potential role of IL-1 beta
52. Caspases as treatment targets in stroke and neurodegenerative diseases
53. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats
54. Neuronal death: Is there a role for astrocytes?
55. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms
56. Association of tissue-specific histones with deoxyribonucleic acid. Thermal denaturation of native, partially dehistonized, and reconstituted chromatins
57. Vascular endothelial growth/permeability factor in spinal cord injury
58. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist
59. Fas/APO-1 gene transfer for human malignant glioma
60. Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas
61. Specific inhibition of apoptosis after cold-induced brain injury by moderate postinjury hypothermia
62. Peripheral nerve graft and neurotrophic factors enhance neuronal survival and expression of nitric oxide synthase in Clarke's nucleus after hemisection of the spinal cord in adult rat
63. Apoptosis in cellular compartments of rat spinal cord after severe contusion injury
64. Clinical trials and experimental therapies of spinal cord injury
65. The role of calcium in spinal cord injury
66. Glucocorticoid therapy of spinal cord injury
67. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: Etiological role of the inflammatory response
68. Immunodetection of histone epitopes correlates with early stages of apoptosis in activated human peripheral T lymphocytes
69. Effects of dexamethasone administration on the posttraumatic demyelinization in an experimental model of spinal cord contusion
70. Presence and significance of CD95 (FAS/APO1) expression after spinal cord injury